Saturday 7 November 2026 Export ACTU’s income statement to Excel — free account

Actuate Therapeutics, Inc.

ACTU Healthcare Biotechnology

EPS: +33.3%
Free cash flow: −5.54%

Quarter to June 2026, against a year earlier

Insider buying

0.33 0.00 0.00%

Follow ACTU

Alert me

Market cap: $18.0M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(296.04%)	(553.75%)	3,304.93%	2,457.65%
ROA Full definition →		(150.86%)	(190.35%)	(321.58%)	(336.18%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(217.86%)	(280.07%)	(567.13%)	(2,169.70%)
Free Cash Flow per Share Full definition →		(0.95)	(0.91)	(0.83)	(0.83)
Free Cash Flow Full definition →		(20.24)	(19.21)	(19.60)	(19.84)
Other line items
Cash ROIC Full definition →		(72.66%)	(91.10%)	(164.49%)	(366.32%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		(1,194.41)	(1,102.72)	(1,070.38)	(1,018.31)
Operating CF/Net income Full definition →		0.84	0.86	0.91	0.97
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.95)	(0.91)	(0.83)	(0.83)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026